Search Results - Michael Sladden
- Showing 1 - 3 results of 3
-
1
BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma Autoría: Anthony J. Dixon, Athanassios Kyrgidis, Michael Sladden, Alexander Nirenberg, Howard K. Steinman, Harvey Smith, Christopher B. Zachary, Stuart Anderson, Ulrike Leiter‐Stöppke, Caterina Longo, Zoe Apalla
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Sentinel lymph node biopsy may no longer be a critical component of melanoma management Autoría: Athanassios Kyrgidis, Anthony J. Dixon, Michael Sladden, Howard K. Steinman, Christos C. Zouboulis, Aimilios Lallas, Samantha Schneider, Harvey Smith, Alexander Nirenberg, Caterina Longo, Giuseppe Argenziano, Catalin Popescu, Thrasyvoulos Tzellos, Stuart Anderson, J. Meirion Thomas
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients Autoría: Anthony J. Dixon, Athanassios Kyrgidis, Howard K. Steinman, John B. Dixon, Michael Sladden, Claus Garbe, Aimilios Lallas, Christopher B. Zachary, Ulrike Leiter‐Stöppke, Harvey Smith, Alexander Nirenberg, Christos C. Zouboulis, Caterina Longo, Giuseppe Argenziano, Zoe Apalla, Catalin Popescu, Thrasyvoulos Tzellos, Stuart Anderson, Lena Nanz, Lloyd Cleaver, J. Meirion Thomas
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso